Cargando…
NUAK2 is a critical YAP target in liver cancer
The Hippo-YAP signaling pathway is a critical regulator of proliferation, apoptosis, and cell fate. The main downstream effector of this pathway, YAP, has been shown to be misregulated in human cancer and has emerged as an attractive target for therapeutics. A significant insufficiency in our unders...
Autores principales: | Yuan, Wei-Chien, Pepe-Mooney, Brian, Galli, Giorgio G., Dill, Michael T., Huang, Hai-Tsang, Hao, Mingfeng, Wang, Yumeng, Liang, Han, Calogero, Raffaele A., Camargo, Fernando D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240092/ https://www.ncbi.nlm.nih.gov/pubmed/30446657 http://dx.doi.org/10.1038/s41467-018-07394-5 |
Ejemplares similares
-
NUAK1 and NUAK2 Fine-Tune TGF-β Signaling
por: van de Vis, Reinofke A. J., et al.
Publicado: (2021) -
A loss-of-function NUAK2 mutation in humans causes anencephaly due to impaired Hippo-YAP signaling
por: Bonnard, Carine, et al.
Publicado: (2020) -
NUAK Kinases: Brain–Ovary Axis
por: Molina, Ester, et al.
Publicado: (2021) -
NUAK2: an emerging acral melanoma oncogene
por: Namiki, Takeshi, et al.
Publicado: (2011) -
NUAK1 links genomic instability and senescence
por: Bernard, David, et al.
Publicado: (2010)